
The IDT Australia Limited (ASX: IDT) share price is crashing down to Earth on Thursday morning.
At the time of writing, the pharmaceutical manufacturing company’s shares are down 37% to 30 cents.
Why is the IDT Australia share price crashing today?
Investors have been selling down the IDT Australia share price today after it was dealt a bitter blow.
Earlier this year, the company announced that it successfully manufactured an mRNA drug product. This made IDT the first in Australia to manufacture a cGMP mRNA drug product.
In light of this, there were hopes that this would support its Australian Government Approach To Market submission to establish an onshore mRNA manufacturing capability (ATM).
However, this morning the Australian Government has confirmed that IDT’s ATM submission has not been selected to progress to the next stage of the process.
IDT’s CEO, Dr David Sparling, commented: “Whilst we are disappointed in the outcome of the ATM process, IDT has developed and progressed several alternative strategic options. The Company has successfully delivered on the Monash Institute of Pharmaceutical Sciences (MIPS) COVID-19 mRNA receptor binding domain vaccine candidate project, being Australia’s first locally manufactured cGMP mRNA finished product and clearly showcases IDT’s manufacturing capabilities in this regard.”
What’s next?
Dr Sparling notes that the company remains in the running for the Manufacturing Collaboration Stream Grant Opportunity.
“IDT is now sterile licenced and is maintaining its sterile facilities in a state of readiness to accept COVID-19 vaccine content at the Government’s discretion. The Company is also waiting to receive feedback on its submission to the Australian Government’s $800m Modern Manufacturing Initiative (MMI) Manufacturing Collaboration Stream Grant Opportunity,” Dr Sparling added.
Positively, the company also stressed that the proposal is unaffected by the outcome of the ATM process. It will provide a market update if and when additional information comes to hand.
The post Why the IDT Australia (ASX:IDT) share price is crashing 37% lower today appeared first on The Motley Fool Australia.
Should you invest $1,000 in IDT right now?
Before you consider IDT, you’ll want to hear this.
Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and IDT wasn’t one of them.
The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.
*Returns as of August 16th 2021
More reading
- Why is the IDT (ASX:IDT) share price halted today?
- IDT (ASX:IDT) share price swings as CEO lauds mRNA tech in fight against Omicron
- The Starpharma (ASX: SPL) share price surges on Vietnam launch
- IDT Australia (ASX:IDT) share price rockets 40% on COVID vaccine update
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.
from The Motley Fool Australia https://ift.tt/3DXJM1u
Leave a Reply